Online citations, reference lists, and bibliographies.
← Back to Search

An Insight On Hyaluronic Acid In Drug Targeting And Drug Delivery

A. Yadav, P. Mishra, G. Agrawal
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Hyaluronic acid (HA) has recently been studied for its use in drug delivery applications. Medically, HA is used as a surgical aid in ophthalmology. It also possesses therapeutic potential in the treatment of arthritis and wound healing. HA-binding receptors, CD44 and receptor for hyaluronan-mediated motility have attracted much enthusiasm, mainly because they are believed to be involved in cancer metastasis. This review unravels the role of HA in drug delivery and targeting. Designing of various novel drug delivery systems using HA as a biopolymer will also be reviewed in the present article.
This paper references
10.4049/jimmunol.165.4.1863
Oligosaccharides of Hyaluronan Are Potent Activators of Dendritic Cells1
C. Termeer (2000)
Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion.
W. Knudson (1996)
10.3109/10611869609046255
Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity.
K. Akima (1996)
10.1016/0378-5173(94)90352-2
Ocular sustained delivery of prednisolone using hyaluronic acid benzyl ester films
L. Hume (1994)
Chitosan as absorption enhancers of poorly absorbable drugs 3: Influence of mucus
NGM Schipper (1999)
10.1016/0378-5173(88)90087-7
Nasal administration of gentamicin using a novel microsphere delivery system
L. Ilium (1988)
10.1016/0378-5173(86)90153-5
Bile salts and intranasal drug absorption
Guus Duchateau (1986)
Lateral interactions among membrane proteins
JR Abney (1987)
10.1023/A:1015867305641
Bile Salt–Fatty Acid Mixed Micelles as Nasal Absorption Promoters of Peptides. II. In Vivo Nasal Absorption of Insulin in Rats and Effects of Mixed Micelles on the Morphological Integrity of the Nasal Mucosa
P. Tengamnuay (2004)
10.1146/ANNUREV.CB.11.110195.003125
Carbohydrate-protein interactions in vascular biology.
R. M. Nelson (1995)
In: Helert AJ, editor
Balazs EA. (1982)
10.1046/j.1365-2796.1997.00171.x
Hyaluronan in morphogenesis
B. Toole (2001)
10.1016/J.UROLONC.2005.08.020
HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer.
A. Rosato (2006)
10.1016/S0928-0987(99)00032-9
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
N. G. Schipper (1999)
10.1021/BC9900338
Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate.
Y. Luo (1999)
The physical properties of synovial fluid and the special role of hyaluronic acid in disorder of the knee. Philadelphia: Liincott
E A Balazs (1982)
Summary of Pre-Clinical and Clinical Development Meditech Research Ltd Non-Confidential Information Package
(2004)
Photocrosslinkable hyaluronic acid hydrogels for tissue engineering
JB Leach (2004)
10.1016/S0142-9612(03)00467-8
Hyaluronan microspheres for sustained gene delivery and site-specific targeting.
Y. H. Yun (2004)
10.1016/0168-3659(94)90129-5
Hyaluronic acid ester microspheres as a nasal delivery system for insulin
L. Illum (1994)
10.1016/J.IJPHARM.2006.05.024
Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition.
S. Hahn (2006)
10.2754/AVB200473010093
Adhesion Molecules in Biology and Oncology
Z. Lukáš (2004)
10.1021/BC00028A015
Biotinylated hyaluronic acid: a new tool for probing hyaluronate-receptor interactions.
T. Pouyani (1994)
10.1248/BPB1978.10.624
Studies on the promoting effects of medium chain fatty acid salts on the nasal absorption of insulin in rats.
M. Mishima (1987)
The chemistry, biology and medical applications of hyaluronan and its derivatives
E. Balazs (1998)
Chemistry and molecular biology of the intercellular matrix
E. Balazs (1970)
10.1016/J.EJPB.2005.07.002
Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization.
G. Sandri (2006)
10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
HA receptors: Regulators of signalling to the cytoskeleton
J. Entwistle (1996)
10.1016/0168-3659(90)90016-M
Nasal administration of insulin using bioadhesive microspheres as a delivery system
N. Farraj (1990)
10.1002/IJC.2910600511
The role of hyaluronan in tumour neovascularization (review)
P. Rooney (1995)
10.1016/S0168-3659(03)00175-5
Characterization of DNA-hyaluronan matrix for sustained gene transfer.
A. Kim (2003)
Viscoelastic properties modulation of a noval hyaluronic acid polymer
M Mensiteri (1996)
In: Lauret TC, editor
GD Prestwich (1998)
10.1023/A:1018528308132
Circulating hyaluronan, chondroitin sulphate and dextran sulphate bind to a liver receptor that does not recognize heparin
S. Gustafson (2004)
10.1016/0092-8674(90)90694-A
CD44 is the principal cell surface receptor for hyaluronate
A. Aruffo (1990)
10.1007/BF00731313
Labelling of high molecular weight hyaluronan with125I-tyrosine: studiesin vitro andin vivo in the rat
S. Gustafson (2004)
10.1016/0168-3659(95)00146-8
The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
G. Borchard (1996)
10.1136/ard.54.5.429
Functions of hyaluronan.
T. Laurent (1995)
10.1021/BC00028A010
Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials.
T. Pouyani (1994)
10.1016/S0006-3495(87)83233-2
Lateral interactions among membrane proteins. Implications for the organization of gap junctions.
J. R. Abney (1987)
Transnasal systemic medications
YW Chien (1985)
10.1002/JOR.20070
Antibiotic‐containing hyaluronic acid gel as an antibacterial carrier: Usefulness of sponge and film‐formed HA gel in deep infection
H. Matsuno (2006)
10.1016/S0014-5793(98)01505-1
Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action
L. Collis (1998)
10.1016/0955-0674(90)90081-O
Hyaluronan and its binding proteins, the hyaladherins.
B. Toole (1990)
10.1007/BF00123409
Viscoelastic properties modulation of a novel autocrosslinked hyaluronic acid polymer
M. Mensitieri (1996)
10.1201/B14099
Bioadhesive Drug Delivery Systems : Fundamentals, Novel Approaches, and Development
E. Mathiowitz (1999)
10.1016/0378-5173(94)00226-U
Novel vaginal delivery systems for calcitonin: I. Evaluation of HYAFF/calcitonin microspheres in rats
J. Richardson (1995)
10.1166/JNN.2006.430
Hemocompatibility of layer-by-layer hyaluronic acid/heparin nanostructure coating on stainless steel for cardiovascular stents and its use for drug delivery.
L. Huang (2006)
10.1016/0168-3659(90)90072-2
Microspheres of hyaluronic acid esters—Fabrication methods and in vitro hydrocortisone release
L. Benedetti (1990)
10.1254/JJP.74.117
Suppression of ischemic edema in mice by manganese-hyaluronate conjugate.
K. Sakurai (1997)
10.1182/BLOOD.V81.2.446.BLOODJOURNAL812446
Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes.
E. Turley (1993)
10.1172/JCI119054
Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.
C. Mckee (1996)
10.1016/S0378-5173(03)00259-X
Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro.
K. Y. Cho (2003)
10.1016/J.IJPHARM.2005.06.006
Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system.
Feng-Feng Lv (2005)
10.1126/SCIENCE.2408340
Angiogenesis induced by degradation products of hyaluronic acid.
D. West (1985)
10.1016/S0168-3659(02)00207-9
Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery
S. Barbault-Foucher (2002)
10.1039/B506989K
Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering.
Motoichi Kurisawa (2005)
10.1016/S0168-3659(03)00263-3
Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs.
K. Surendrakumar (2003)
10.1016/0378-5173(92)90176-3
Enzymic and non-enzymic hydrolysis of a polymeric prodrug : hydrocortisone esters of hyaluronic acid
L. G. Rajewski (1992)
10.1006/ABBI.1994.1387
Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing.
N. Yerushalmi (1994)
10.1016/0142-9612(93)90160-4
Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats.
L. Benedetti (1993)
BIOADHESIVE FORMULATIONS FOR NASAL PEPTIDE DELIVERY
L. Illum (1999)
Bile salts fatty acid mixed micelles as nasal absorption promoters of peptides
P Tengamnuay (1990)
10.1111/j.2042-7158.1985.tb05024.x
Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel
K. Morimoto (1985)
10.1038/NBT0794-689
Biodegradable Polymer Scaffolds for Tissue Engineering
L. Freed (1994)
10.1021/BM0607426
Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
C. Meo (2007)
Adhesion Molecules in Biology and Oncology
Z. Luka
10.1016/S0934-8832(11)80100-9
Binding and internalization of hyaluronate by human cutaneous fibroblasts.
C. Bertolami (1992)
10.1016/0378-5173(90)90232-S
Characterization of degradable starch microspheres as a nasal delivery system for drugs
E. Björk (1990)
10.1016/S0168-3659(99)00285-0
Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan.
S. T. Lim (2000)
10.1023/A:1015170907274
Targeted Delivery of Doxorubicin by HPMA Copolymer-Hyaluronan Bioconjugates
Yi Luo (2004)
Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant lymphocytes-B
EA Turley (1993)
Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells.
T. K. Yeo (1996)
10.1080/02713689808951267
Effects of daunomycin implants on filtering surgery outcomes in rabbits.
J. Morales (1998)
10.1016/0378-5173(81)90009-0
Effect of surfactants on the nasal absorption of insulin in rats
Hirai Shinichiro (1981)
10.1007/S00776-006-1059-0
A new antibacterial carrier of hyaluronic acid gel
H. Matsuno (2006)
10.1016/S0378-5173(01)00873-0
In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits.
S. T. Lim (2002)
10.1163/156856205774472353
Preparation of a hyaluronic acid hydrogel through polyion complex formation using cationic polylactide-based microspheres as a biodegradable cross-linking agent
Hidetoshi Arimura (2005)
10.1007/S10856-006-0600-1
A novel hydrogel crosslinked hyaluronan with glycol chitosan
W. Wang (2006)
10.1021/BC00017A001
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.
H. Maeda (1992)
10.1126/SCIENCE.8134835
New challenges in biomaterials.
N. Peppas (1994)
THE POLYSACCHARIDE OF THE VITREOUS HUMOR
K. Meyer (1934)
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
R. E. Eliaz (2001)
10.4324/9780203483411
An introduction to polysaccharide biotechnology
M. P. Tombs (1998)
10.1111/j.2042-7158.1987.tb03398.x
The effect of molecular size on the nasal absorption of water‐soluble compounds in the albino rat
A. Fisher (1987)
10.1016/0378-5173(95)04280-6
Evaluation of the bioadhesive properties of hyaluronan derivatives: Detachment weight and mucociliary transport rate studies
K. Pritchard (1996)
10.1046/j.1365-2796.1997.00173.x
Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation
B. Gerdin (1997)
10.1016/J.BMC.2005.04.084
Recent advances in tumor-targeting anticancer drug conjugates.
Stanislav Jaracz (2005)
10.1016/0092-8674(95)90048-9
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation
C. L. Hall (1995)
Water-soluble polysaccharide-anthracycline conjugates: biological activity.
C. Cera (1992)
10.3109/03008209309041327
Identification of hyaluronan binding proteins using a biotinylated hyaluronan probe.
K. Hoare (1993)
Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid.
H. Uchiyama (1990)
10.1002/JBM.A.30759
Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin.
K. Motokawa (2006)
10.1016/J.BIOMATERIALS.2006.12.012
Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone.
Taichi Ito (2007)
10.1016/S0168-3659(00)00300-X
Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery.
Y. Luo (2000)
Hyaluronan (HA) fragment induce chemikine gene expression in alveolar macrophares
CM Mckee (1996)
10.1016/J.IJPHARM.2004.09.001
Hyaluronan-based microspheres as tools for drug delivery: a comparative study.
E. Esposito (2005)
10.1021/BC050239A
Synthesis and evaluation of hydrolyzable hyaluronan-tethered bupivacaine delivery systems.
Diego A. Gianolio (2005)
10.1021/BC0600721
Efficient synthesis of an aldehyde functionalized hyaluronic acid and its application in the preparation of hyaluronan-lipid conjugates.
Dipali Ruhela (2006)
10.1002/JPS.2600800803
Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.
W. Lee (1991)
10.1046/j.1365-2796.1997.00170.x
Hyaluronan: its nature, distribution, functions and turnover
J. E. Fraser (1997)
10.1021/AR9800993
Biomaterials in drug delivery and tissue engineering: one laboratory's experience.
R. Langer (2000)
Nasal administration of insulin using bioadhesive microspheres and lysophosphatidylcholine as a delivery system
NF Farraj (1990)
Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.
K. Goa (1994)
10.1002/9780470513774.CH16
Clinical uses of hyaluronan.
E. Balazs (1989)
10.1083/JCB.117.6.1343
Correction. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
C. Hardwick (1992)
10.1016/J.ADDR.2005.07.004
The use of mucoadhesive polymers in vaginal delivery.
C. Valenta (2005)
10.1083/JCB.116.4.1055
The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan
M. Culty (1992)



This paper is referenced by
Review Article Hyaluronan regulation of vascular integrity
Frances E. Lennon (2011)
10.3109/10611860903225727
Drug in adhesive type transdermal matrix systems of ondansetron hydrochloride: optimization of permeation pattern using response surface methodology
K. Swain (2010)
10.1007/978-981-32-9840-8_13
Nanobiomaterials in Drug Delivery: Designing Strategies and Critical Concepts for Their Potential Clinical Applications
Chang Liu (2020)
10.1016/B978-0-08-055294-1.00073-8
2.214 – Hyaluronic Acid
J.-W. Kuo (2011)
10.1021/mp800024g
Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
Virginia M Platt (2008)
10.1002/9783527652457.CH9
Associating Biopolymer Systems and Hyaluronate Biomaterials
Deborah A. Blanchard (2013)
10.1016/j.ijpharm.2014.11.048
Preactivated hyaluronic acid: A potential mucoadhesive polymer for vaginal delivery.
J. Nowak (2015)
10.1016/j.ijbiomac.2013.11.027
Biodistribution profiling of the chemical modified hyaluronic acid derivatives used for oral delivery system.
Chien-Ming Hsieh (2014)
Hyaluronan regulation of vascular integrity.
F. Lennon (2011)
10.1002/9781119041450.CH5
BIOMASS-DERIVED AND BIOMASS-INSPIRED POLYMERS IN PHARMACEUTICAL APPLICATIONS
E. Bartzoka (2015)
10.4018/978-1-4666-9811-6.CH011
Bioinspired Materials and Biocompatibility
M. Anil (2016)
10.1186/2055-7124-18-6
Purification and biocompatibility of fermented hyaluronic acid for its applications to biomaterials
SungChul Choi (2014)
10.1016/B978-012374178-3.10020-1
Exploiting the Hyaluronan–CD44 Interaction for Cancer Therapy
Virginia M Platt (2009)
10.1016/B978-0-12-803581-8.10180-8
4.31 Cell-Demanded Release of Growth Factors☆
V. Milleret (2017)
10.1002/MABI.201100352
Injectable hydrogel for sustained protein release by salt-induced association of hyaluronic acid nanogel.
T. Nakai (2012)
10.1002/9781118015810.CH1
Biodegradable Polymers in Drug Delivery
J. Jain (2011)
10.1016/j.ijbiomac.2018.12.104
Grafted hyaluronic acid N-acetyl-l-methionine for targeting of LAT1 receptor: In-silico, synthesis and microscale thermophoresis studies.
Ayman Yahia Waddad (2019)
10.1016/j.carbpol.2012.09.042
Comb-like ionic complexes of hyaluronic acid with alkyltrimethylammonium surfactants.
Ainhoa Tolentino (2013)
10.1016/j.ijbiomac.2016.02.032
Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine.
M. Hemshekhar (2016)
10.1016/j.tifs.2020.05.001
Development of active food packaging via incorporation of biopolymeric nanocarriers containing essential oils
Abdur Rehman (2020)
10.1016/B978-0-08-055294-1.00152-5
Cell-Demanded Release of Growth Factors
A. Zisch (2011)
10.1002/adhm.201700918
Developing a Clinically Relevant Tissue Engineered Heart Valve—A Review of Current Approaches
Aline L Y Nachlas (2017)
10.1016/j.msec.2019.01.051
Amination degree of gelatin is critical for establishing structure-property-function relationships of biodegradable thermogels as intracameral drug delivery systems.
Li-Jyuan Luo (2019)
10.1007/978-981-15-3262-7_9
Biocompatibility of Materials for Biomedical Engineering.
Yu-Chang Tyan (2020)
10.1016/j.ijpharm.2014.08.030
Synthesis and optimization of a novel polymeric micelle based on hyaluronic acid and phospholipids for delivery of paclitaxel, in vitro and in-vivo evaluation.
E. Saadat (2014)
10.1002/9781119640240.ch11
Vaginal Bioadhesive Drug Delivery Systems and Their Applications
Anju Sharma (2020)
10.1016/j.colsurfb.2016.05.009
Electrosprayed nanocomposites based on hyaluronic acid derivative and Soluplus for tumor-targeted drug delivery.
S. Lee (2016)
10.1016/j.colsurfb.2017.02.030
Multifunctional nanoparticles self-assembled from polyethylenimine-based graft polymers as efficient anticancer drug delivery.
Jianqin Yan (2017)
Kwas hialuronowy – charakterystyka, otrzymywanie i zastosowanie
D. Czajkowska (2011)
10.1016/J.CARBPOL.2019.05.067
Review of polysaccharide particle-based functional drug delivery.
Thomas G Barclay (2019)
10.1021/bm2014476
One-step "click" method for generating vinyl sulfone groups on hydroxyl-containing water-soluble polymers.
Y. Yu (2012)
10.1016/j.carbpol.2017.05.017
Bio-stimuli-responsive multi-scale hyaluronic acid nanoparticles for deepened tumor penetration and enhanced therapy.
Mengmeng Huo (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar